Randomized phase III study for the treatment of advanced indolent non-Hodgkin's lymphomas (NHL) and mantle cell lymphoma: chemotherapy versus chemotherapy plus rituximab

Ann Hematol. 2003 Feb;82(2):77-9. doi: 10.1007/s00277-002-0581-1. Epub 2003 Feb 5.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase III
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / toxicity
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / toxicity
  • Chlorambucil / administration & dosage
  • Clinical Protocols
  • Humans
  • Lymphoma, Mantle-Cell / drug therapy*
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Middle Aged
  • Mitoxantrone / administration & dosage
  • Patient Selection
  • Prednisolone / administration & dosage
  • Prospective Studies
  • Remission Induction / methods
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Chlorambucil
  • Rituximab
  • Prednisolone
  • Mitoxantrone